Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000420549 | SCV000526748 | likely benign | not specified | 2017-08-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000654705 | SCV000776604 | benign | Familial hyperkalemic periodic paralysis | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002506051 | SCV002807621 | likely benign | Hypokalemic periodic paralysis, type 1; Potassium-aggravated myotonia; Paramyotonia congenita of Von Eulenburg; Hypokalemic periodic paralysis, type 2; Familial hyperkalemic periodic paralysis; Congenital myasthenic syndrome 16 | 2021-09-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004584711 | SCV005074109 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | SCN4A: BP4 |
Breakthrough Genomics, |
RCV004584711 | SCV005211225 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004539848 | SCV004757056 | likely benign | SCN4A-related disorder | 2019-03-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |